Table 5.
Simulated causal variable | ||||
---|---|---|---|---|
Homocysteine concentration | Pyrimidine synthesis (TS) | Purine synthesis (AICART) | DNA methylation (DNMT) | |
Genetic main effects | ||||
G2: TS | 0.06 (0.10) | -0.97 (0.11) | 0.15 (0.11) | 0.12 (0.10) |
G3: MTD | -0.35 (0.11) | 1.09 (0.12) | -0.81 (0.12) | 0.59 (0.11) |
G4: MTCH | -0.26 (0.14) | 0.60 (0.13) | -0.68 (0.14) | 0.35 (0.12) |
G5: PGT | 0.01 (0.05) | 0.05 (0.18) | -1.90 (0.19) | -0.04 (0.16) |
G7: FTS | 0.13 (0.12) | 0.06 (0.14) | -0.62 (0.13) | 0.11 (0.12) |
G8: FTD | -0.12 (0.13) | -0.34 (0.14) | 0.59 (0.13) | -0.26 (0.12) |
G9: SHMT | 0.29 (0.12) | -0.72 (0.10) | -0.53 (0.12) | -0.43 (0.10) |
G10: MTHFR | 0.34 (0.10) | -0.04 (0.10) | 0.13 (0.11) | -0.70 (0.11) |
G11: MS | 0.23 (0.10) | -0.18 (0.10) | -0.47 (0.11) | -0.13 (0.10) |
G12: SAHH | -0.78 (0.13) | 0.22 (0.13) | 0.34 (0.14) | -0.54 (0.12) |
G13: CBS | 1.43 (0.13) | 0.07 (0.12) | 0.06 (0.12) | 0.01 (0.11) |
Prior covariates | ||||
π1: homocysteine | 1.65 (0.81) | -0.16 (0.63) | -0.02 (0.70) | 0.00 (0.57) |
π2: vTS | -0.18 (0.57) | 1.45 (0.61) | 0.08 (0.62) | 0.17 (0.54) |
π3: vAICART | 0.11 (0.59) | 20.35 (0.61) | 2.19 (0.81) | -0.28 (0.55) |
π4: vDNMT | -0.01 (0.69) | 0.27 (0.69) | -0.01 (0.70) | 1.01 (0.73) |
Posterior standard deviations (SDs) | ||||
σβ = SD(β|Z) | 0.49 (0.12) | 0.48 (0.11) | 0.52 (0.11) | 0.47 (0.11) |
σπ = SD(π) | 1.14 (0.48) | 1.14 (0.47) | 1.33 (0.58) | 0.99 (0.40) |
Bolded entries have posterior credibility intervals that exclude zero
AICART, aminoimidazolecarboxamide ribonucleotide transferase; CBS, cystathionine b-reductase; DNMT, DNA methyltransferase; FTD, 10-formyltetrahydrofolate dehydrogenase; FTS, 10-formyltetrahydrofolate synthase; MS, methionine synthase; MTCH, 5,10-methylenetetrahydrofolate cyclohydrolase; MTD, 5,10-methylenetetrahydrofolate dehydrogenase; MTHFR, 5,10-methylenetetrahydrofolate reductase; PGT, phosphoribosyl glycinamide transferase; SAHH, S-adenosylhomocysteine; SHMT, serine hydroxymethyltransferase; TS, thymidylate synthase.